Clinical Trials
12 trialsNCT06172296 2026-06-03
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
National Cancer Institute (NCI)
Phase 3 Recruiting
NCT06203210 2026-06-02
IDeate-Lung02
Daiichi Sankyo
Phase 3 Recruiting
NCT06619236 2026-06-02
RAINFOL-02
Genmab
Phase 3 Active not recruiting
NCT07604766 2026-06-02
RAINFOL-02
Genmab
Phase 3 Not yet recruiting
NCT07214779 2026-06-01
MAESTRA 2
Incyte Corporation
Phase 3 Recruiting
NCT06459180 2026-05-27
TroFuse-020
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT07099898 2026-05-27
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
GlaxoSmithKline
Phase 3 Recruiting
NCT07213804 2026-05-27
FRAmework-01
Eli Lilly and Company
Phase 3 Recruiting
NCT07286266 2026-05-27
A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)
GlaxoSmithKline
Phase 3 Not yet recruiting
NCT06612151 2026-05-26
A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 3 Active not recruiting
NCT06616532 2026-05-22
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
Biotheus Inc.
Phase 3 Active not recruiting
NCT06801834 2026-05-20
EVOKE-SCLC-04
Gilead Sciences
Phase 3 Recruiting